Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Rarbar99 on Aug 25, 2021 10:00pm

Be prepared.

Although I'm bullish on this company in the long run. Expect a drop to 0.80-0.90 as early as next month. And a possible crash down to 0.60 depending on how October's report will go. 

It is what it is, these numbers are all very real possibilities. DCA if you're bullish but please don't think for a second that we've bottomed out. We can still drop another 50% from here.

Comment by YukonJezza on Aug 26, 2021 12:58am
congratulations on selling today.
Comment by IrishCanuck on Aug 26, 2021 7:30am
"I better say a lot of prices because if I hit one I can seem prophetic" 
Comment by Rarbar99 on Aug 26, 2021 8:11pm
You mean when I was constantly telling y'all to sell at $1.40-$1.50 3 weeks ago? and then I told y'all to buy at $1.15 last week? like it or not, my predictions have been very accurate. And I'm not saying it will go below sub $1, I'm just saying it's very possible. I won't be surprised if it does.
Comment by Inthepez on Aug 27, 2021 2:35pm
Just shut up. You flip flop more than a fish out of water. I’m sure “after much research” you’ll be back to bash. Rinse and repeat.  Anymore car pics you want share, incel? LOL! 
Comment by MrMugsy on Aug 26, 2021 8:39am
You think the share price can go down to half cash value ?  I’ve never seen that. you must also think there is no high dose option if we don’t find a low dose option - I think that’s way off base. To get to 60 cents ... we’d need to run out of options and burn through half our cash within a few months. Cant personally see it happening.
Comment by Doccole on Aug 26, 2021 4:16pm
I'm not a chart guy, but looking at the short position, anything is possible.   If they come back and abandon this drug to focus on other molecules.  It could fall through bad. im just holding and trying not to pay too much attention.  We are a long time out, unless they can sell the company or some decent news.  I would love a positive catalyst and the shorts covering ...more  
Comment by Inthepez on Aug 26, 2021 5:53pm
You@re right if they abandon the drug.which could happen. But I doubt it now that the amalgamation is complete. If the SP tanks, it@ll hurt management hard. They haven@t been at risk as much as the retail shareholder till now.@
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities